Scenarios that move IONS
Ionis Pharmaceuticals, Inc. - Common Stock
Scenarios that move IONS: 6 analyses, 3 positive, 3 negative.
- · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▲ · impact +32 · confidence high · horizon immediate
- · uniQure plunges after additional Huntington's disease study data — ▲ · impact +32 · confidence medium · horizon weeks
- · ADARx Pharmaceuticals prices upsized $446.3 million initial public offering — ▼ · impact -24 · confidence low · horizon quarters
- · Ionis reports positive late-stage results for two partnered drugs — ▲ · impact +88 · confidence high · horizon immediate
- · FDA approves Isembyld for spinal muscular atrophy treatment — ▼ · impact -45 · confidence low · horizon quarters
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▼ · impact -82 · confidence high · horizon immediate